Skip to content

Single blinded evaluation of the effectiveness of Neuro Psycho Physical Optimization protocol with Radio Electric Asymmetric Conveyer in stress-related disorders, assessed with Symptom Checklist-90 (SCL-90) and Psychological Stress Measure Test.

Single blinded evaluation of the effectiveness of Neuro Psycho Physical Optimization protocol with Radio Electric Asymmetric Conveyer in stress-related disorders, assessed with Symptom Checklist-90 (SCL-90) and Psychological Stress Measure Test.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12609000484246
Acronym
sbsclmsp
Enrollment
120
Registered
2009-06-18
Start date
2003-12-02
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The aim of this study is evaluate the efficacy of the Neuro Psycho Physical Optimization (NPPO) protocol treatment with Radioelectric Asymmetric Conveyer (REAC) in the improvement of the psychic and symptomatic stress-related disorders in a group of subjects revealing high values of psychological stress. These randomized, single-blinded controlled study, was conducted on subjects that voluntarily came to our Institute declaring to “feel stressed”. One hundred twenty four (124) subjects (females, n = 81, males, n = 43) with psychological distress symptoms, were recruited an randomized to REAC therapy or placebo. Eighteen sessions of NPPO protocol treatment with REAC, or placebo (inactivated REAC), was applied to seven specific points of the auricular pavilion and were administered on alternate days, lasting about four weeks. Psychological stress symptoms were assessed by Psychological Stress Measure (PSM) and Symptomatic Check List (SCL-90), pre and post intervention. Data were analyzed using the Statistical Package for Social Sciences (SPSS), version 13.0 Data conformed to a Gaussian distribution. There was a significant reduction in PSM test and SCL-90 scores in the treated group as compared to the placebo group. Results of the psychometric tests showed that the subjects that underwent the effective therapy showed a statistically relevant reduction in their level of stress and psychological disorders compared to the control placebo group.

Interventions

The intervention comprises: A cycle of auricular treatment protocol with Radioelectric Asymetric Conveyer (REAC). The REAC is a Radioelectric medical device. The protocol used, called Neuro Psycho Physical Optimization (ONPF), involves the application of a probe of the REAC on specific points of the auricular pavilion for an activation time of roughly 500 mms. The ONPF protocol is activated in a precise sequence on seven auricular points. . The protocol envisages 18 sessions of ONPF treatment l

The intervention comprises: A cycle of auricular treatment protocol with Radioelectric Asymetric Conveyer (REAC). The REAC is a Radioelectric medical device. The protocol used, called Neuro Psycho Physical Optimization (ONPF), involves the application of a probe of the REAC on specific points of the auricular pavilion for an activation time of roughly 500 mms. The ONPF protocol is activated in a precise sequence on seven auricular points. . The protocol envisages 18 sessions of ONPF treatment lasting approximately 3,5 seconds each on alternating days, for eight (8) weeks. Assessment, at baseline and immediately at the end of treatment, with SCL-90 and Psychological Stress Measure Test

Sponsors

Istituto Rinaldi Fontani
Lead SponsorCharities/Societies/Foundations

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Healthy Subjects without organic diseases, over 18 years old, who claimed to be stressed, with any type of stress-related symptoms and with Psychological stress measure test (PSM) total score over 45 points. No history of drug abuse, nor severe mental illness or personality disorder. No medications, known to affect cognitive functioning nor undergoing psychological interventions.

Exclusion criteria

Diagnosis of psychiatric pathology, organic central nervous system (CNS) pathology, preceding skull traumas with loss of conscience longer than 5 minutes, dementia, alcohol dependence, current therapy with medications known to affect cognitive functioning.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026